151 related articles for article (PubMed ID: 19770290)
1. Relationship between antibiotic consumption and Clostridium difficile-associated diarrhea: an epidemiological note.
Kaier K; Frank U
Antimicrob Agents Chemother; 2009 Oct; 53(10):4574-5. PubMed ID: 19770290
[No Abstract] [Full Text] [Related]
2. Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients.
Aldeyab MA; Harbarth S; Vernaz N; Kearney MP; Scott MG; Funston C; Savage K; Kelly D; Aldiab MA; McElnay JC
Antimicrob Agents Chemother; 2009 May; 53(5):2082-8. PubMed ID: 19289520
[TBL] [Abstract][Full Text] [Related]
3. Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
Johnson S; Gerding DN; Louie TJ; Ruiz NM; Gorbach SL
Antimicrob Agents Chemother; 2012 Aug; 56(8):4043-5. PubMed ID: 22615287
[No Abstract] [Full Text] [Related]
4. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection: new developments in epidemiology and pathogenesis.
Rupnik M; Wilcox MH; Gerding DN
Nat Rev Microbiol; 2009 Jul; 7(7):526-36. PubMed ID: 19528959
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of linezolid against Clostridium difficile.
Peláez T; Alonso R; Pérez C; Alcalá L; Cuevas O; Bouza E
Antimicrob Agents Chemother; 2002 May; 46(5):1617-8. PubMed ID: 11959617
[TBL] [Abstract][Full Text] [Related]
7. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.
Akerlund T; Persson I; Unemo M; Norén T; Svenungsson B; Wullt M; Burman LG
J Clin Microbiol; 2008 Apr; 46(4):1530-3. PubMed ID: 18287318
[TBL] [Abstract][Full Text] [Related]
8. Trés difficile.
Wilkins E
J Infect; 1993 Jan; 26(1):1-7. PubMed ID: 8454879
[No Abstract] [Full Text] [Related]
9. Clostridium difficile associated disease in Thailand.
Wongwanich S; Ramsiri S; Vanasin B; Khowsaphit P; Tantipatayangkul P; Phan-urai R
Southeast Asian J Trop Med Public Health; 1990 Sep; 21(3):367-72. PubMed ID: 2075479
[TBL] [Abstract][Full Text] [Related]
10. Clostridioides (Clostridium) difficile infection in hospitalized patients with antibiotic-associated diarrhea: A systematic review and meta-analysis.
Nasiri MJ; Goudarzi M; Hajikhani B; Ghazi M; Goudarzi H; Pouriran R
Anaerobe; 2018 Apr; 50():32-37. PubMed ID: 29408016
[TBL] [Abstract][Full Text] [Related]
11. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
Carman RJ; Boone JH; Grover H; Wickham KN; Chen L
Antimicrob Agents Chemother; 2012 Nov; 56(11):6019-20. PubMed ID: 22908175
[TBL] [Abstract][Full Text] [Related]
12. Poor infection control, not fluoroquinolones, likely to be primary cause of Clostridium difficile-associated diarrhea outbreaks in Quebec.
Weiss K
Clin Infect Dis; 2006 Mar; 42(5):725-7; author reply 727-9. PubMed ID: 16447121
[No Abstract] [Full Text] [Related]
13. Growing consumption of antibiotics and epidemiology of Clostridioides difficile infections in Poland: A need to develop new solutions.
Jachowicz E; Pobiega M; Różańska A; Wójkowska-Mach J
Acta Microbiol Immunol Hung; 2020 Jun; 67(2):79-86. PubMed ID: 31813263
[TBL] [Abstract][Full Text] [Related]
14. Influence of ceftriaxone on emergence of Clostridium difficile.
Lejko-Zupanc T; Zakelj J; Strle F; Janc M; Pleterski-Rigler D
Antimicrob Agents Chemother; 1992 Dec; 36(12):2850-1. PubMed ID: 1482159
[TBL] [Abstract][Full Text] [Related]
15. Interactions between Lactobacilli and antibiotic-associated diarrhea.
Naaber P; Mikelsaar M
Adv Appl Microbiol; 2004; 54():231-60. PubMed ID: 15251283
[No Abstract] [Full Text] [Related]
16. Characterization of Circulating Clostridium difficile Strains, Host Response and Intestinal Microbiome in Hospitalized Children With Diarrhea.
Lees EA; Carrol ED; Ellaby NAF; Roberts P; Corless CE; Lenzi L; Darby A; O'Brien SJ; Cunliffe NA; Turner MA; Miyajima F; Pirmohamed M
Pediatr Infect Dis J; 2020 Mar; 39(3):221-228. PubMed ID: 31876614
[TBL] [Abstract][Full Text] [Related]
17. [Debatable questions on Clostridium difficile diarrhea].
Burman LG
Lakartidningen; 1992 Jan; 89(4):196-7. PubMed ID: 1734150
[No Abstract] [Full Text] [Related]
18. Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004.
Weiss K; Bergeron L; Bernatchez H; Goyette M; Savoie M; Thirion D
Int J Antimicrob Agents; 2007 Oct; 30(4):309-14. PubMed ID: 17644347
[TBL] [Abstract][Full Text] [Related]
19. Incidence of diarrhea and Clostridium difficile toxin in stools from hospitalized patients receiving clindamycin, beta-lactams, or nonantibiotic medications.
Thamlikitkul V; Danpakdi K; Chokloikaew S
J Clin Gastroenterol; 1996 Mar; 22(2):161-3. PubMed ID: 8742665
[No Abstract] [Full Text] [Related]
20. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.
McFarland LV; Ozen M; Dinleyici EC; Goh S
World J Gastroenterol; 2016 Mar; 22(11):3078-104. PubMed ID: 27003987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
